Mitsuho Imai

594 total citations
24 papers, 360 citations indexed

About

Mitsuho Imai is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mitsuho Imai has authored 24 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mitsuho Imai's work include Cancer Genomics and Diagnostics (5 papers), IgG4-Related and Inflammatory Diseases (3 papers) and Gastrointestinal disorders and treatments (3 papers). Mitsuho Imai is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), IgG4-Related and Inflammatory Diseases (3 papers) and Gastrointestinal disorders and treatments (3 papers). Mitsuho Imai collaborates with scholars based in Japan, United States and France. Mitsuho Imai's co-authors include Terumi Kamisawa, Kouji Tsuruta, Atsutake Okamoto, Naoto Egawa, Yuyang Tu, Noriko Kamata, Mizuka Suzuki, Akira Horii, Tetsu Akiyama and Tsutomu Nakamura and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Mitsuho Imai

22 papers receiving 356 citations

Peers

Countries citing papers authored by Mitsuho Imai

Since Specialization

Citations

This map shows the geographic impact of Mitsuho Imai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuho Imai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuho Imai more than expected).

Fields of papers citing papers by Mitsuho Imai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuho Imai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuho Imai. The network helps show where Mitsuho Imai may publish in the future.

Co-authorship network of co-authors of Mitsuho Imai

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuho Imai. A scholar is included among the top collaborators of Mitsuho Imai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuho Imai. Mitsuho Imai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	777P Spatial transcriptomic dynamics of the tumour microenvironment after chemoradiotherapy followed by immune checkpoint blockade in locally advanced rectal cancer: A translational study from VOLTAGE trial 2025 ·Annals of Oncology ·Hideaki Bando, (unknown), Yuichiro Tsukada, Su Jin Lee, (unknown), (unknown), Takeshi Kato, (unknown), Yoshito Komatsu, Akinobu Taketomi, Masashi Wakabayashi, (unknown), Akihiro Sato, Hiroyoshi Nishikawa, Masaaki Ito, Shingo Sakashita, Mitsuho Imai, (unknown), Tateki Yoshino	0
2	Transforming cancer screening: the potential of multi-cancer early detection (MCED) technologies 2025 ·International Journal of Clinical Oncology ·Mitsuho Imai, Yoshiaki Nakamura, Takayuki Yoshino	6
3	Artificial Intelligence–Powered Human Epidermal Growth Factor Receptor 2 and Tumor Microenvironment Analysis in Human Epidermal Growth Factor Receptor 2–Amplified Metastatic Colorectal Cancer: Exploratory Analysis of Phase II TRIUMPH Trial 2025 ·JCO Precision Oncology ·Mitsuho Imai, Yoshiaki Nakamura, Sangwon Shin, Wataru Okamoto, Takeshi Kato, Taito Esaki, Ken Kato, Yoshito Komatsu, (unknown), Toshiki Masuishi, (unknown), Kentaro Sawada, Akihiro Sato, Takeshi Kuwata, Riu Yamashita, (unknown), Hideaki Bando, Chan‐Young Ock, (unknown), Takayuki Yoshino	2
4	SpatialKNifeY (SKNY): Extending from spatial domain to surrounding area to identify microenvironment features with single-cell spatial omics data 2025 ·PLoS Computational Biology ·(unknown), Ryosuke Nomura, Satoi Nagasawa, (unknown), Ayako Suzuki, Yutaka Suzuki, Mitsuho Imai, Yoshiaki Nakamura, Takayuki Yoshino, Shumpei Ishikawa, Katsuya Tsuchihara, Shun‐Ichiro Kageyama, Riu Yamashita	0
5	Whole‐transcriptome sequencing in advanced gastric or gastroesophageal cancer: A deep dive into its clinical potential 2024 ·Cancer Science ·Tadayoshi Hashimoto, Yoshiaki Nakamura, Saori Mishima, Izuma Nakayama, Daisuke Kotani, Akihito Kawazoe, Yasutoshi Kuboki, Hideaki Bando, Takashi Kojima, Naoko Iida, Taro Shibuki, Mitsuho Imai, Takao Fujisawa, (unknown), Naoya Sakamoto, Takeshi Kuwata, Takayuki Yoshino, Kohei Shitara	9
6	Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor-2–Negative Metastatic Breast Cancer Treated With Abemaciclib: Data From the SCRUM-Japan Cancer Genome Screening Project 2024 ·JCO Precision Oncology ·Masaya Hattori, (unknown), Yoichi Naito, Takashi Yamanaka, Hiroyuki Yasojima, Rikiya Nakamura, Takao Fujisawa, Mitsuho Imai, Yoshiaki Nakamura, Hideaki Bando, Tsutomu Kawaguchi, Takayuki Yoshino, Hiroji Iwata	2
7	Artificial intelligence (AI)-powered HER2 quantification continuous score (QCS) and tumor microenvironment (TME) analysis in HER2-amplified metastatic colorectal cancer (mCRC) treated with pertuzumab plus trastuzumab. 2023 ·JCO Global Oncology ·Mitsuho Imai, Yoshiaki Nakamura, Wataru Okamoto, Takeshi Kato, Taito Esaki, Ken Kato, Yoshito Komatsu, Satoshi Yuki, Toshiki Masuishi, Tomohiro Nishina, Akihiro Sato, Takeshi Kuwata, (unknown), Takao Fujisawa, Hideaki Bando, Jongchan Park, (unknown), Chan‐Young Ock, Satoshi Fujii, Takayuki Yoshino	2
8	Chronological improvement in precision oncology implementation in Japan 2022 ·Cancer Science ·Kuniko Sunami, Yoichi Naito, Keigo Komine, Toraji Amano, Daisuke Ennishi, Mitsuho Imai, Hidenori Kage, Masashi Kanai, Hirotsugu Kenmotsu, Takafumi Koyama, Takahiro Maeda, Sachi Morita, Daisuke Sakai, Shinji Kohsaka, Katsuya Tsuchihara, Yusuke Saigusa, Takayuki Yoshino	15
9	Genetic profiling of patients with adenoid cystic carcinoma of the Bartholin’s glands reveals potential new routes for targeted therapies: a case report 2020 ·Diagnostic Pathology ·Kohei Nakamura, Eriko Aimono, Shigeki Tanishima, Hidetaka Nomura, Mitsuho Imai, Hideyuki Hayashi, Hiroshi Nishihara	11
10	National Survey of Japan for Myeloablative Total Body Irradiation Prior to Hematopoietic Stem Cell Transplantation 2017 ·International Journal of Radiation OncologyBiologyPhysics ·Naoya Ishibashi, Toshinori Soejima, Hiroki Kawaguchi, Masahiko Oguchi, (unknown), Masatoshi Hasegawa, Koichi Isobe, Yasuo Ejima, Hideto Ito, Mitsuho Imai, (unknown), (unknown), Tetsuo Akimoto	1
11	National Survey on Total Body Irradiation Before Reduced-Intensity Stem Cell Transplantation in Japan 2017 ·International Journal of Radiation OncologyBiologyPhysics ·Hiroki Kawaguchi, Naoya Ishibashi, Toshinori Soejima, Masahiko Oguchi, Masatoshi Hasegawa, K. Isobe, Hideto Ito, Mitsuho Imai, Yasuo Ejima, (unknown), (unknown), (unknown), Tetsuo Akimoto	1
12	Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion 2010 ·Biochemical and Biophysical Research Communications ·Yoshinari Asaoka, Motohisa Tada, Tsuneo Ikenoue, Motoko Seto, Mitsuho Imai, Koji Miyabayashi, Keisuke Yamamoto, Shinzo Yamamoto, Yotaro Kudo, Dai Mohri, Yoshihiro Isomura, Hideaki Ijichi, Keisuke Tateishi, Fumihiko Kanai, Seishi Ogawa, Masao Omata, Kazuhiko Koike	57
13	Strategy for differentiating autoimmune pancreatitis from pancreatic cancer 2009 ·Suizo ·Terumi Kamisawa, Mitsuho Imai, (unknown), Yuyang Tu, Naoto Egawa, Kouji Tsuruta, Atsutake Okamoto, Mizuka Suzuki, Noriko Kamata	7
14	Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)--initial analysis. 2008 ·PubMed ·Yuzuru Niibe, (unknown), (unknown), Mitsuho Imai, Keitaro Matsuo, Keiji Matsunaga, Nobuya Unno, (unknown)	17
15	Serum IgG4 levels and extrapancreatic lesions in autoimmune pancreatitis 2008 ·European Journal of Gastroenterology & Hepatology ·Terumi Kamisawa, Mitsuho Imai, Naoto Egawa, Kouji Tsuruta, Atsutake Okamoto	35
16	Strategy for Differentiating Autoimmune Pancreatitis From Pancreatic Cancer 2008 ·Pancreas ·Terumi Kamisawa, Mitsuho Imai, (unknown), Yuyang Tu, Naoto Egawa, Kouji Tsuruta, Atsutake Okamoto, Mizuka Suzuki, Noriko Kamata	113
17	Infrequent somatic mutations of the ICAT gene in various human cancers with frequent 1p-LOH and/or abnormal nuclear accumulation of β-catenin 2004 ·Oncology Reports ·Mitsuho Imai, Tsutomu Nakamura, Tetsu Akiyama, Akira Horii	14
18	Spontaneous rupture of bladder diverticulum after postoperative radiotherapy for carcinoma of the uterine cervix: a case report. 2001 ·PubMed ·T. Nishimura, Koichi Suzuki, (unknown), M Nozue, Mitsuho Imai, Shin Suzuki, Harumi Sakahara, Nobuo Ohta, Masako Kasami	19
19	Perianal mucinous carcinoma successfully treated with a combination of external beam radiotherapy and high dose rate interstitial brachytherapy. 2000 ·British Journal of Radiology ·T. Nishimura, M Nozue, (unknown), Mitsuho Imai, Sayaka Suzuki, Harumi Sakahara, Tatsuya Nakamura, Hiroshi Sugimura	8
20	ECG changes during cerebral angiography 1984 ·Neuroradiology ·Katsumi Hayakawa, (unknown), Masaki Yoshida, Kazuhiro ITOH, Naokazu Hayashi, Junya Aoki, Kenji Nakamura, Mitsuho Imai, Takao Ono, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact